These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26559079)

  • 1. Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?
    Currie GP; Lipworth BJ
    QJM; 2016 Aug; 109(8):505-12. PubMed ID: 26559079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Corticosteroids for Chronic Obstructive Pulmonary Disease--The Shifting Treatment Paradigm.
    Wilkie M; Finch S; Schembri S
    COPD; 2015; 12(5):582-90. PubMed ID: 25774769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 4. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment of stable COPD: need for a simplified approach.
    Hillas G; Papaporfyriou A; Dimakou K; Papaioannou AI
    Postgrad Med; 2020 Mar; 132(2):126-131. PubMed ID: 31852408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overuse of long-acting β
    Brunton SA; Hogarth DK
    Postgrad Med; 2023 Nov; 135(8):784-802. PubMed ID: 38032494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current evidence for COPD management with dual long-acting muscarinic antagonist/long-acting β
    Skolnik NS; Nguyen TS; Shrestha A; Ray R; Corbridge TC; Brunton SA
    Postgrad Med; 2020 Mar; 132(2):198-205. PubMed ID: 31900019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
    Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Long-Acting Muscarinic Antagonist/Long-Acting β
    Petite SE
    Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perplexing mortality data from triple therapy trials in COPD.
    Suissa S
    Lancet Respir Med; 2021 Jul; 9(7):684-685. PubMed ID: 34126054
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of use of long-acting bronchodilators in patients with COPD: A nationwide follow-up study of new users in New Zealand.
    Parkin L; Barson D; Zeng J; Horsburgh S; Sharples K; Dummer J
    Respirology; 2018 Jun; 23(6):583-592. PubMed ID: 29265705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the role of triple inhaled therapy in COPD?
    Petite SE
    JAAPA; 2019 Oct; 32(10):44-45. PubMed ID: 31567741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care.
    Landis SH; Wurst K; Le HV; Bonar K; Punekar YS
    COPD; 2017 Feb; 14(1):80-85. PubMed ID: 27819513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.
    Contoli M; Corsico AG; Santus P; Di Marco F; Braido F; Rogliani P; Calzetta L; Scichilone N
    COPD; 2017 Dec; 14(6):641-647. PubMed ID: 29116901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?
    Salama RO; Young PM; Rogueda P; Lallement A; Iliev I; Traini D
    Expert Opin Pharmacother; 2011 Aug; 12(12):1913-32. PubMed ID: 21714776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function changes over time following withdrawal of inhaled corticosteroids in patients with severe COPD.
    Magnussen H; Tetzlaff K; Bateman ED; Watz H; Kirsten AM; Wouters EF; Disse B; Finnigan H; Rodriguez-Roisin R; Calverley PM
    Eur Respir J; 2016 Feb; 47(2):651-4. PubMed ID: 26585433
    [No Abstract]   [Full Text] [Related]  

  • 20. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.